Latest Close
$29.08
Stock Hub
SGP
SpyGlass Pharma, Inc.
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
$2.68 (+10.15%)
Market Cap
$972,667,264.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
52W Range
$17.06 to $32.44
Target Mean Price
$44.00
Beta
Not available
Trailing P/E
Not available
Forward P/E
-10.70
Price / Book
4.19
Company Overview
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.